The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Longitudinal study of normal cognition in Parkinson disease
Open accessAbstract
OBJECTIVE: To report the rates and predictors of progression from normal cognition to either mild cognitive impairment (MCI) or dementia using standardized neuropsychological methods. METHODS: A prospective cohort of patients diagnosed with Parkinson disease (PD) and baseline normal cognition was assessed for cognitive decline, performance, and function for a minimum of 2 years, and up to 6. A panel of movement disorders experts classified patients as having normal cognition, MCI, or dementia, with 55/68 (80.9%) of eligible patients seen at year 6. Kaplan-Meier curves and Cox proportional hazard models were used to examine cognitive decline and its predictors. RESULTS: We enrolled 141 patients, who averaged 68.8 years of age, 63% men, who had PD on average for 5 years. The cumulative incidence of cognitive impairment was 8.5% at year 1, increasing to 47.4% by year 6. All incident MCI cases had progressed to dementia by year 5. In a multivariate analysis, predictors of future decline were male sex (p = 0.02), higher Unified Parkinson's Disease Rating Scale motor score (p ≤ 0.001), and worse global cognitive score (p < 0.001). CONCLUSIONS: Approximately half of patients with PD with normal cognition at baseline develop cognitive impairment within 6 years and all new MCI cases progress to dementia within 5 years. Our results show that the transition from normal cognition to cognitive impairment, including dementia, occurs frequently and quickly. Certain clinical and cognitive variables may be useful in predicting progression to cognitive impairment in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A 6-year longitudinal study of 141 PD patient with average disease duration of 5 years and a mean age of 69 years showed a cumulative risk of dementia increasing from 8.5% at 1 year to nearly 50% by year 6 (Pigott et al. 2015).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Pigott et al. 2015
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationOverdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R. L., Patel, S., Rick, C., Gray, R. G., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,310
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,168
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659 · cited 1×
“These findings are in contrast to those reported for MCI in the general population, in which the majority of patients will not progress to dementia even after 10 years of follow-up.(26) Using total DRS-2 score to control for global cognitive performance at baseline, demographic predictors of progression to cognitive i…”
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams‐Gray, C. H., Evans, J., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 1,017
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 928
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams‐Gray, C. H., Mason, S., Evans, J., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 683
Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia
Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006) · Movement Disorders · doi:10.1002/mds.20974 · Cited by 592
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson, P., Westman, E., Ballard, C. G., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 517
Burn, D. J. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 437
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G. W., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D. A., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 422
Self-citationGeda, Y. E., Roberts, R. O., Mielke, M. M., Knopman, D. S., Christianson, T. J. H., Pankratz, V. S., Boeve, B. F., Sochor, O., Tangalos, E. G., Petersen, R. C., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13060821 · Cited by 352
Prognosis of Mild Cognitive Impairment in Early Parkinson Disease: The Norwegian ParkWest Study
Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2110 · Cited by 315
Szewczyk‐Królikowski, K., Tomlinson, P. R., Nithi, K. A., Wade‐Martins, R., Talbot, K., Ben‐Shlomo, Y., & Hu, M. T. M. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.025 · Cited by 293
Weintraub, D. A., Oehlberg, K. A., Katz, I. R., & Stern, M. B. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192488.66049.4b · Cited by 279
Self-citationShared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease
Xie, A., Gao, J., Xu, L., & Meng, D.-M. (2014) · BioMed Research International · doi:10.1155/2014/648740 · Cited by 204
Motoric cognitive risk syndrome
Verghese, J., Ayers, E. I., Barzilai, N., Bennett, D. A., Buchman, A. S., Holtzer, R., Katz, M. J., Lipton, R. B., & Wang, C. (2014) · Neurology · doi:10.1212/wnl.0000000000001084 · Cited by 200
Neuropsychological characteristics of preclinical dementia in Parkinson's disease
Jacobs, D. M., Marder, K. S., Cote, L. J., Sano, M. C., Stern, Y., & Mayeux, R. P. (1995) · Neurology · doi:10.1212/wnl.45.9.1691 · Cited by 186
Cognitive impairment in early-stage non-demented Parkinson's disease patients
Pfeiffer, H. C. V., Løkkegaard, A., Zoetmulder, M., Friberg, L., & Werdelin, L. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12189 · Cited by 162
Genetic influences on cognitive decline in Parkinson's disease
Morley, J. F., Xie, S. X., Hurtig, H. I., Stern, M. B., Colcher, A., Horn, S. S., Dahodwala, N. A., Duda, J. E., Weintraub, D. A., Chen‐Plotkin, A. S., et al. (2012) · Movement Disorders · doi:10.1002/mds.24946 · Cited by 152
Self-citationCognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
Broeders, M., Velseboer, D. C., de Bie, R. M. A., Speelman, J. D., Muslimović, D., Post, B., de Haan, R. J., & Schmand, B. A. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000295 · Cited by 99
Winter, Y., von Campenhausen, S., Arend, M., Longo, K., Boetzel, K., Eggert, K. M., Oertel, W. H., Dodel, R. C., & Barone, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.003 · Cited by 85
Kudlicka, A., Clare, L., & Hindle, J. V. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3970 · Cited by 82
Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia
Matteau, E., Dupré, N., Langlois, M., Provencher, P., & Simard, M. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712445086 · Cited by 63
Watson, G. S., Cholerton, B., Gross, R. G., Weintraub, D. A., Zabetian, C. P., Trojanowski, J. Q., Montine, T. J., Siderowf, A. D., & Leverenz, J. B. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.07.006 · Cited by 29
Self-citation
Research works printed but not linked: 1
- Jurica PJ, Leitten SL, Mattis S. Dementia Rating Scale-2 (DRS-2): Professional Manual. Odessa, FL: Psychological Assessment Resources; 2001.
Cited by
Sorted by citations
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C. G., Chaudhuri, К. R., & Weintraub, D. A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,540
Self-citationThe clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
Self-citationIrwin, D. J., Grossman, M., Weintraub, D. A., Hurtig, H. I., Duda, J. E., Xie, S. X., Lee, E. B., Deerlin, V. M. V., López, O. L., Kofler, J., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30291-5 · Cited by 606
Self-citation
Metadata
- Authors
- Pigott, K., Rick, J., Xie, S. X., Hurtig, H., Chen-Plotkin, A., Duda, J. E., Morley, J. F., Chahine, L. M., Dahodwala, N., Akhtar, R. S., Siderowf, A., Trojanowski, J. Q., & Weintraub, D.
- Affiliations
- Veterans Health Administration (US)
- From the Departments of Neurology (K.P., J.R., H.H., A.C.-P., J.E.D., J.F.M., L.M.C., N.D., R.S.A., D.W.), Pathology and Laboratory Medicine (J.Q.T.), and Psychiatry (D.W.), Perelman School of Medicine at the University of Pennsylvania; the Department of Biostatistics and Epidemiology (S.X.X.), University of Pennsylvania; Philadelphia Veterans Affairs Medical Center (J.E.D., J.F.M., D.W.); and Avid Radiopharmaceuticals (A.S.), Philadelphia, PA.
- ORCID
- Venue
- Neurology
- Published
- 2015-10-13
- Volume
- 85
- Issue
- 15
- Pages
- 1276-1282
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4617168
- OpenAlex
- W1414124913
- Cited by
- 251
- References
- 34
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 26 · 2023: 23 · 2022: 28 · 2021: 27 · 2020: 24 · 2019: 19 · 2018: 24 · 2017: 30 · 2016: 18 · 2015: 1
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Michael J. Fox Foundation for Parkinson's Research
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- American Brain Foundation
- CHDI Foundation
- Teva Pharmaceutical Industries
- University of Pennsylvania
- ACADIA Pharmaceuticals
- Avanir Pharmaceuticals
- H. Lundbeck A/S
- National Institutes of Health (AG 17586, NS053488)
- Avid Radiopharmaceuticals
- National Institute on Aging (AG 024904, AG 029213, AG-19724, P30AG010124, P01AG017586, AG17586, AG-10124, U01AG029213, K23AG034236, P01AG032953, P01AG019724)
- National Institute of Neurological Disorders and Stroke (NS053488, P50NS053488, K08NS093127, U01NS082134, UO1 NS082134)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, cognitive impairment, mild cognitive impairment, dementia, cognitive decline, conversion to dementia, predictors of cognitive decline, sex differences, motor score, Unified Parkinson's Disease Rating Scale
- MeSH terms
- Aged, Cognition, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Parkinson Disease, Prospective Studies, Disease Progression, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
